PHARMAVAC PHA / PARAMYXOVIRUS, HERPESVIRUS, ADENOVIRUS / 50 DOSES

Pharmavac PHA 50 doses   Composition Per dose of 0.3 ml:   Pigeon paramyxovirus 1 (PPMV1), inactivated, 988M strain ≥ 6.9 log2 HI * Pigeon herpesvirus 1 (PHV1), inactivated, strain V298 / 70 ≥38.1 EU ** Poultry adenovirus type 8 (FAdV-8), inactivated, strain M2 / E ≥24.7 EU ** * Inhibition of haemagglutination in chicks ** ELISA units in chickens   Waiting times Pigeon: meat and offal: 0 days   Indications Pigeon: For the active immunization of pigeons from the age of 4 weeks to:   Reduction of mortality, frequency and severity of clinical symptoms caused by paramyxovirus type 1 (PMV1). Reduction of the severity of clinical symptoms, large lesions and the shedding of viruses caused by the pigeon herpes virus (PHV1). Reduction of the severity of clinical symptoms and large lesions caused by the adenovirus (AdV) of types 7 / E, 2 / D, 3 / D and 4 / C belonging to subgroup I. Onset of immunity  3 weeks after vaccination.   Duration of immunity 12 months after vaccination for the PMV1 component and 5 months after vaccination for the PHV1 and AdV components. Duration of immunity to PHV1 and AdV was demonstrated based on cell-mediated immunity and serological data.   Storage and transport  Store at 2° C ± 8° C. Store in the original carton. Transport at 2° C ± 16° C, protected from sunlight.